Glucose Health, Inc. (GLUC)
OTCMKTS
· Delayed Price · Currency is USD
0.420
-0.050 (-10.60%)
Mar 9, 2026, 9:55 AM EST
Glucose Health Revenue
Glucose Health had revenue of $340.68K in the quarter ending September 30, 2022, with 18.66% growth. This brings the company's revenue in the last twelve months to $1.11M, up 131.47% year-over-year. In the year 2021, Glucose Health had annual revenue of $953.68K with 98.39% growth.
Revenue (ttm)
1.11M
Revenue Growth
+131.47%
P/S Ratio
12.06
Revenue / Employee
370.90K
Employees
3
Market Cap
13.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 953.68K | 472.97K | 98.39% |
| Dec 31, 2020 | 480.71K | 167.48K | 53.47% |
| Dec 31, 2016 | 313.23K | 308.96K | 7,232.14% |
| Dec 31, 2015 | 4.27K | 1.53K | 55.97% |
| Dec 31, 2014 | 2.74K | 2.52K | 1,122.77% |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Foods Holdings | 422.40K |
| DAVIDsTEA | 43.33M |
| Integrated BioPharma | 52.09M |
| Starco Brands | 47.15M |
| Global Pharmatech | 3.18M |
| Elamex SA de CV | 110.74M |
| Hi-Great Group Holding Company | 48.03K |
| Limitless X Holdings | 1.13M |